Serum CEA level is associated comorbidity of hemodialysis patients

Hemodialysis affects biomarkers concentration in blood. The aim of this study is to evaluate the effects of hemodialysis on commonly used tumor markers. A total of 28 unselected patients (22 men and 6 women) with end-stage renal disease (ESRD), treated with maintenance hemodialysis, were enrolled in this study. GOT and tumor markers such as CA-153, CA-125, and CEA are measured. The mean age was 57.6 ± 12.6 years with 51.0 ± 34.0 months hemodialysis duration. Our results indicated that tumor marker CEA level is correlated to Charlson’s score of hemodialysis patients whereas level of CA153 and CA125 is not correlated to age, duration of dialysis and Charlson’s score. GOT level is correlated to age, and Charlson’s score. In conclusion, concentration of CEA is correlated with Charlson’s score which strongly correlated with hemodialysis outcome. GOT value is correlated with age and Charlson’s score which implies liver function drop in long term hemodialysis patients. [I-Hung Chen, Jeng-Chuan Shiang, Ming-Kai Tsai, Fu-Hsin Chang, Wen-Sheng Liu, Chi-Ting Horng, Hsueh-Wei Chang, Li-Sung Hsu, Hurng-Wern Huang. Serum CEA level is associated comorbidity of hemodialysis patients. Life Sci J 2017;14(7):22-25]. ISSN: 1097-8135 (Print) / ISSN: 2372-613X (Online). http://www.lifesciencesite.com. 4. doi:10.7537/marslsj140717.04.